insights_auto
Prečo akcie ALMKT stúpli 5,17%?
Preskúmať podrobnejšiechevron_right
ALMKT:EPA
Mauna Kea Technologies SA
0,13 €
arrow_upward
+5,17%(+0,0062) 1 d.
6. 10., 11:51:13 GMT+2 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre ALMKT…
Otvoriť
0,12 €
Vysoká
0,13 €
Nízka
0,12 €
Trh. kap.
25,50 mil.
Priem. obj.
488,81 tis.
Objem
138,63 tis.
Pomer cena/zárobky
1,03
Max. za 52 týž.
0,23 €
Min. za 52 týž.
0,07 €
Výnosy na akciu
0,12 €
Akcie v obehu
195,26 mil.
Počet zamestnancov
59
Otvoriť
0,12 €
Vysoká
0,13 €
Nízka
0,12 €
Trh. kap.
25,50 mil.
Priem. obj.
488,81 tis.
Objem
138,63 tis.
Pomer cena/zárobky
1,03
Max. za 52 týž.
0,23 €
Min. za 52 týž.
0,07 €
Výnosy na akciu
0,12 €
Akcie v obehu
195,26 mil.
Počet zamestnancov
59
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
EQS News
·
pred 31 minútami
Solidion Technology (NASDAQ: STI) Sees no Basis to Increase Its Offer to Polar Power, Inc. (NASDAQ: POLA) in Response to Board Rejection of All-Cash Asset Acquisition Proposal | Corporate
Axios
·
pred 1 hodinou
Wall Street is on track for record profits
Simply Wall Street
·
pred 1 hodinou
Will Mood And Mind Drinks Change Walmart's (WMT) Narrative
Reuters
·
pred 12 minútami
Wall St futures rise as yields, oil dip
Profil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Informácie o subjekte Mauna Kea Technologies SA
Generálny riaditeľSacha Loiseau
Zamestnanci59
Dátum založenia2000
Hlavné sídlo-
Odvetvie-